Alembic Pharmaceuticals has reported results for second quarter ended September 30, 2023 (Q2FY24).
The company has reported 8.60% fall in its net profit at Rs 133.84 crore for the quarter under review as compared to Rs 146.44 crore for the same quarter in the previous year. However, total income of the company increased by 9.81% at Rs 1,487.79 crore for Q2FY24 as compared to Rs 1,354.88 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 2.41% rise in its net profit at Rs 136.56 crore for Q2FY24 as compared to Rs 133.35 crore for the same quarter in the previous year. Total income of the company increased by 8.79% at Rs 1,605.08 crore for Q2FY24 as compared to Rs 1,475.34 crore for the corresponding quarter previous year.
